Latest filing published 09 Jun 2023 for Krystal Biotech, Inc., €625k.
Filing timeline
BuySaleInsider track record
Andrew C. Orth: trading record in brief
Andrew C. Orth is a declared insider of Krystal Biotech, Inc., with filings sourced from SEC (Form 4). Altogether 4 filings, all relating to 9 June 2023.
Sales make up the whole of the open-market record (3 sales, €1.5M). The rest of the record consists of 1 option exercise.
The newest entry dates from 9 June 2023: an open-market sale of €625k, in Krystal Biotech, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew C. Orth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,261 shares@ US$128.1028.1% of flowCommon StockSEC:0001860010-23-000004:1
- 6,906 shares@ US$128.9437.1% of flowCommon StockSEC:0001860010-23-000004:2
- 333 shares@ US$129.701.8% of flowCommon StockSEC:0001860010-23-000004:3
- 12,500 shares@ US$63.55100.0% of flowCommon StockSEC:0001860010-23-000004:0
4 of 4 declarations
